Bluestone JA - Search Results

1

Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.

Hirsch R, Bluestone JA, DeNenno L, Gress RE. Hirsch R, et al. Among authors: bluestone ja. Transplantation. 1990 Jun;49(6):1117-23. doi: 10.1097/00007890-199006000-00018. Transplantation. 1990. PMID: 2141740

2

Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.

Hirsch R, Bluestone JA, Bare CV, Gress RE. Hirsch R, et al. Among authors: bluestone ja. Transplant Proc. 1991 Feb;23(1 Pt 1):270-1. Transplant Proc. 1991. PMID: 1824981 No abstract available.

3

Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.

Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA. Hirsch R, et al. Among authors: bluestone ja. J Immunol. 1989 Feb 1;142(3):737-43. J Immunol. 1989. PMID: 2521507

4

Suppression of the humoral response to anti-CD3 mAB by pretreatment with anti-CD4 mAB.

Hirsch R, Chatenoud L, Gress RE, Bach JF, Sachs DH, Bluestone JA. Hirsch R, et al. Among authors: bluestone ja. Transplant Proc. 1989 Feb;21(1 Pt 1):1015-6. Transplant Proc. 1989. PMID: 2523111 No abstract available.

5

Suppression of the humoral response to anti-CD3 monoclonal antibody.

Hirsch R, Chatenoud L, Gress RE, Sachs DH, Bach JF, Bluestone JA. Hirsch R, et al. Among authors: bluestone ja. Transplantation. 1989 May;47(5):853-7. doi: 10.1097/00007890-198905000-00021. Transplantation. 1989. PMID: 2524123

6

In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growth.

Hirsch R, Ellenhorn JD, Bluestone JA. Hirsch R, et al. Among authors: bluestone ja. Princess Takamatsu Symp. 1988;19:237-43. Princess Takamatsu Symp. 1988. PMID: 2978618

7

Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space.

Hiruma K, Hirsch R, Patchen M, Bluestone JA, Gress RE. Hiruma K, et al. Among authors: bluestone ja. Blood. 1992 Jun 1;79(11):3050-8. Blood. 1992. PMID: 1534027 Free article.

8

Dose-dependent activation of murine T cells following in vivo administration of anti-murine CD3.

Ellenhorn JD, Hirsch R, Hartley JP, Bluestone JA. Ellenhorn JD, et al. Among authors: bluestone ja. Transplant Proc. 1989 Feb;21(1 Pt 1):1013-4. Transplant Proc. 1989. PMID: 2523110 No abstract available.

9

T helper 2 (Th2) but not Th1 clones co-stimulate resting T cells in the presence of anti-CD3 monoclonal antibody.

Evavold BD, Yokoyama A, Hirsch R, Bluestone JA, Quintans J. Evavold BD, et al. Among authors: bluestone ja. Int Immunol. 1989;1(4):443-9. doi: 10.1093/intimm/1.4.443. Int Immunol. 1989. PMID: 2535137

10

In vivo administration of anti-CD3 prevents malignant progressor tumor growth.

Ellenhorn JD, Hirsch R, Schreiber H, Bluestone JA. Ellenhorn JD, et al. Among authors: bluestone ja. Science. 1988 Oct 28;242(4878):569-71. doi: 10.1126/science.2902689. Science. 1988. PMID: 2902689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters